Cargando…
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Malignant ascites caused by peritoneal dissemination of gastric cancer is chemotherapy-resistant and associated with poor prognosis. We conducted a pilot study to evaluate the safety of weekly intraperitoneal injections of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment...
Autores principales: | Wada, Ikuo, Matsushita, Hirokazu, Noji, Shuichi, Mori, Kazuhiko, Yamashita, Hiroharu, Nomura, Sachiyo, Shimizu, Nobuyuki, Seto, Yasuyuki, Kakimi, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987085/ https://www.ncbi.nlm.nih.gov/pubmed/24515916 http://dx.doi.org/10.1002/cam4.196 |
Ejemplares similares
-
Robotic-assisted totally transhiatal lymphadenectomy in the middle mediastinum for esophageal cancer
por: Mori, Kazuhiko, et al.
Publicado: (2013) -
Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study
por: Kakimi, Kazuhiro, et al.
Publicado: (2020) -
Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor‐infiltrating cells
por: Sato, Yasuyoshi, et al.
Publicado: (2020) -
Established gastric cancer cell lines transplantable into C57BL/6 mice show fibroblast growth factor receptor 4 promotion of tumor growth
por: Yamamoto, Masami, et al.
Publicado: (2018) -
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer
por: Di Mascolo, Daniele, et al.
Publicado: (2019)